Yanbu National Petrochemical (2290) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
28 Jul, 2026Executive summary
Annual revenue declined to SR 5.60 billion in 2025 from SR 6.16 billion in 2024, with net income dropping to SR 79.1 million from SR 420.3 million year-over-year.
Gross profit margin decreased, and earnings per share fell to SR 0.14 from SR 0.75 year-over-year.
The company maintained strong liquidity, ending the year with SR 174.6 million in cash and cash equivalents.
Financial highlights
Revenue: SR 5.60 billion in 2025, down 9% year-over-year.
Net income: SR 79.1 million in 2025, down 81% year-over-year.
Gross profit: SR 646.4 million in 2025, down from SR 954.1 million in 2024.
Total assets: SR 13.26 billion at year-end 2025, down from SR 14.12 billion in 2024.
Dividends: SR 562.5 million distributed for the first half of 2025; another SR 562.5 million approved for the second half.
Outlook and guidance
Scheduled 25-day shutdown of the Ethylene Glycol plant in early 2026 for preventive maintenance, expected to support operational reliability and new product introductions.
No further significant subsequent events expected to materially impact financial position.
Latest events from Yanbu National Petrochemical
- Net income rose sharply to SAR 270 million for H1 2026, with a SAR 562.5 million dividend approved.2290
Q2 2026 - Q1 2026 revenue and net income declined amid a planned shutdown and regional instability.2290
Q1 2026 - Profitability surged in H1 2024 on higher sales and prices, with a SAR 562.5 million dividend approved.2290
Q2 2024 - Returned to profitability in 2024 with SR 420.3 million net income and strong dividend payouts.2290
Q4 2024 - Net income surged to SAR 454.9 million on strong revenue growth and improved margins.2290
Q3 2024 - Net income fell 86% year-over-year as higher feedstock costs eroded margins despite revenue growth.2290
Q1 2025 - Net income fell significantly on higher feedstock costs, but a SAR 562.5m dividend was approved.2290
Q2 2025 - Net income and margins fell sharply on higher feedstock costs and workforce optimization charges.2290
Q3 2025